“At abcam, we put in an enormous amount of work into confirming the specificity of the antibodies,” Solache explains. The company uses knock-out cell lines to eliminate doubts about cross ...

The IWGAV recommended application testing and knock-out validation as key pillars for the validation of RUO antibodies 4, which Abcam has been doing for many years. The company has now raised the ...

Founded in Cambridge in 1998, biotech firm Abcam made a name for itself producing high-quality, validated antibodies for research. The company was listed on NASDAQ in 2020, and was eventually ...